Barry Sternlicht, Elliot Cooperstone and Lewis Gold, MD, who together own about 36 percent of Cano Health shares, recently resigned from the struggling provider to form an investor group aimed at ousting CEO Marlow Hernandez, DO, and at turning the company around.
The letter says Cano has “lost all credibility with its shareholders” in the way it has eaten through cash with ill-advised acquisitions. It also raises questions about Dr. Hernandez and business relationships with family members, something it terms as “deeply troubling.”
These include claims Cano Health paid $23 million to a company controlled by Dr. Hernandez’s father for general contractor work at Cano facilities and an $8.5 million payment to a dental services provider owned by Dr. Hernandez’s wife. Dr. Hernandez’s brother and mother are also dentists employed by a dental provider where his wife sits on the board and which offers services to Cano Health, the letter claims.
“How can Cano shareholders be sure that these Hernandez family arrangements are negotiated at arm’s-length, at market rates and have been fully disclosed to shareholders?” the letter asks.
Cano Health reported a $428 million loss in 2022 on revenue of $2.7 billion. The company declined to comment on the contents of the letter.
The full letter can be found here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
